Company Filing History:
Years Active: 2003-2006
Title: John David Allard: Innovator in Aggrecanase Research
Introduction
John David Allard is a notable inventor based in Cupertino, CA (US). He has made significant contributions to the field of biotechnology, particularly in the area of aggrecanase research. With a total of 2 patents, Allard's work has implications for various therapeutic applications.
Latest Patents
Allard's latest patents include innovations related to human aggrecanase and nucleic acid compositions encoding the same. These patents provide polypeptides and nucleic acid compositions that are useful in research, diagnostics, and therapeutic agent screening applications. Furthermore, the patents outline methods for inhibiting aggrecanase activity in hosts and treating disease conditions associated with aggrecanase activity, such as rheumatoid arthritis, osteo-arthritis, infectious arthritis, gouty arthritis, psoriatic arthritis, spondolysis, sports injury, joint trauma, pulmonary disease, and fibrosis.
Career Highlights
John David Allard is currently employed at Syntex (U.S.A.) Inc., where he continues to advance his research in aggrecanase. His work is pivotal in developing new therapeutic strategies for diseases related to joint and connective tissue disorders.
Collaborations
Allard has collaborated with notable colleagues, including Paul Klonowski and Renu Anand Ileller. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field.
Conclusion
John David Allard's innovative work in aggrecanase research highlights his commitment to improving therapeutic options for various diseases. His contributions are significant in the ongoing quest for effective treatments in the biomedical field.